BCL2L1 and breast cancer: Both arsenic compounds upregulate expression levels of antiapoptotic genes BCL2 and BCL2L1 and downregulate expression levels of proapoptotic genes CASP8 and CASP9, promoting apoptosis in breast cancer cells.